- OMER has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.8 million.
- OMER has traded 17,984 shares today.
- OMER is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in OMER with the Ticky from Trade-Ideas. See the FREE profile for OMER NOW at Trade-Ideas More details on OMER: Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. Currently there are 2 analysts that rate Omeros a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Omeros has been 368,400 shares per day over the past 30 days. Omeros has a market cap of $590.5 million and is part of the health care sector and drugs industry. The stock has a beta of 2.65 and a short float of 20.6% with 8.48 days to cover. Shares are up 53.9% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.